Immune dysregulation in long COVID patients uncovered in new study

Sstudy reveals significant immune changes in long COVID patients, including altered T cell responses and systemic inflammation, using advanced ‘omics’ and serological assays.

Cybin to Present at Public Ventures Discovery Day on March 19th in Dallas | Psychedelic Invest

Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (“Cybin” or the “Company”), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative next-generation psychedelic-based

March 18, 2024

Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 27, 2025 – Biotech Investments

Rancho Cucamonga, 02/20/2025 / 13:05, PST/PDT – EQS Newswire – Amphastar Pharmaceuticals, Inc. RANCHO CUCAMONGA, CA / ACCESS Newswire / February 20, 2025 / Amphastar

February 21, 2025

Feasibility Study with Evonik Confirms LEON’s FR-JET Technology’s Performance in Advanced Nanoparticle Manufacturing for Drug Delivery – Biotech Investments

EQS-News: leon-nanodrugs GmbH / Key word(s): Study results Feasibility Study with Evonik Confirms LEON’s FR-JET Technology’s Performance in Advanced Nanoparticle Manufacturing for Drug Delivery 05.12.2024

December 6, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.